The effects of microglia-associated neuroinflammation on Alzheimer's disease

Cuicui Wang1, Shuai Zong1, Xiaolin Cui2

  • 1Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Insights

Neuroinflammation, driven by microglia, plays a key role in Alzheimer's disease (AD) pathogenesis. Understanding microglial changes and their interactions offers new diagnostic and therapeutic avenues for AD.

Area of Science:

  • Neuroscience
  • Immunology
  • Neuropathology

Background:

  • Alzheimer's disease (AD) is a chronic neurodegenerative disorder.
  • The amyloid cascade hypothesis, focusing on beta-amyloid (Aβ) plaques, has limitations in explaining AD pathogenesis.
  • Emerging evidence highlights the critical role of neuroinflammation in AD development.

Purpose of the Study:

  • To summarize the impact of microglia-mediated neuroinflammation on Alzheimer's disease.
  • To explore the dynamic changes in microglial phenotypes.
  • To review interactions between microglia, Aβ, tau, and neurons in AD.

Main Methods:

  • Review of current literature on neuroinflammation in Alzheimer's disease.
  • Analysis of temporal and spatial changes in microglial phenotypes.
  • Examination of molecular and cellular interactions in AD pathology.

Main Results:

  • Microglia activation and altered phenotypes are central to AD progression.
  • Neuroinflammation significantly influences the interplay between Aβ, tau pathology, and neuronal dysfunction.
  • Elevated inflammatory markers and AD risk genes linked to innate immunity confirm neuroinflammation's role.

Conclusions:

  • Neuroinflammation, particularly microglia-mediated, is a critical factor in Alzheimer's disease.
  • Targeting microglial pathways presents promising diagnostic and therapeutic strategies for AD.
  • Further research into neuroinflammation offers new hope for combating AD.